Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

npj Vaccines (10)
Scientific Reports (4)
Nature Nanotechnology (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (13)
Amendments and Corrections (3)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Biotechnology
Diseases
Drug discovery
Immunology
Microbiology
Molecular medicine
Nanoscience and technology
Structural biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–16 of 16 results

Advanced filters: Author: Sheetij Dutta Clear advanced filters

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection

Kelly E. Seaton
Rachel L. Spreng
S. Moses Dennison
ResearchOpen Access30 Aug 2021
npj Vaccines

Volume: 6, P: 1-13
Role of malaria exposure and off-target responses on RTS,S/AS02_A vaccine immunogenicity and protection in Mozambican children

Elisa Fuentes
Chenjerai Jairoce
Carlota Dobaño
ResearchOpen Access06 Jun 2025
npj Vaccines

Volume: 10, P: 1-10
A candidate antibody drug for prevention of malaria

Isolation and optimization of antibodies targeting the malaria parasite may offer the potential for immediate protection as a prophylactic intervention to prevent severe disease.

Katherine L. Williams
Steve Guerrero
Daniel E. Emerling
ResearchOpen Access02 Jan 2024
Nature Medicine

Volume: 30, P: 117-129
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Mixing antigens with liposomes containing cobalt porphyrin leads to the spontaneous formation of a malaria nanovaccine with increased uptake by phagocytic antigen-presenting cells, boosting the production of long-lasting functional antibodies in mice and rabbits.

Wei-Chiao Huang
Bingbing Deng
Jonathan F. Lovell
Research08 Oct 2018
Nature Nanotechnology

Volume: 13, P: 1174-1181
Restricted valency (NPNA)_n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum

Mark D. Langowski
Farhat A. Khan
Sheetij Dutta
ResearchOpen Access27 Jan 2022
npj Vaccines

Volume: 7, P: 1-11
Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model

Christopher J. Genito
Katherine Brooks
Sheetij Dutta
ResearchOpen Access10 Aug 2023
npj Vaccines

Volume: 8, P: 1-11
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)

Merricka C. Livingstone
Alexis A. Bitzer
Sheetij Dutta
ResearchOpen Access05 Mar 2021
Scientific Reports

Volume: 11, P: 1-15
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Katherine L. Mallory
Justin A. Taylor
Evelina Angov
ResearchOpen Access18 Jun 2021
npj Vaccines

Volume: 6, P: 1-12
Antibody responses to the RTS,S/AS01_E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

Lina Sánchez
Marta Vidal
Carlota Dobaño
ResearchOpen Access04 Jun 2020
npj Vaccines

Volume: 5, P: 1-16
Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

Jason A. Bailey
Andrea A. Berry
Christopher V. Plowe
ResearchOpen Access03 Mar 2020
Scientific Reports

Volume: 10, P: 1-12
Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya

Grace E. Weber
Michael T. White
Arlene E. Dent
ResearchOpen Access04 Dec 2017
Scientific Reports

Volume: 7, P: 1-12
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Margherita Coccia
Catherine Collignon
Arnaud M. Didierlaurent
ResearchOpen Access08 Sept 2017
npj Vaccines

Volume: 2, P: 1-14
Author Correction: Antibody responses to the RTS,S/AS01_E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

Lina Sánchez
Marta Vidal
Carlota Dobaño
Amendments and CorrectionsOpen Access08 Aug 2022
npj Vaccines

Volume: 7, P: 1
Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis

Sidhartha Chaudhury
Jason A. Regules
Elke S. Bergmann-Leitner
ResearchOpen Access11 Aug 2017
Scientific Reports

Volume: 7, P: 1-10
Author Correction: Antibody responses to the RTS,S/AS01_E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

Lina Sánchez
Marta Vidal
Carlota Dobaño
Amendments and CorrectionsOpen Access20 Jul 2020
npj Vaccines

Volume: 5, P: 1
Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Margherita Coccia
Catherine Collignon
Arnaud M. Didierlaurent
Amendments and CorrectionsOpen Access21 Mar 2018
npj Vaccines

Volume: 3, P: 1

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Italy
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection

Role of malaria exposure and off-target responses on RTS,S/AS02_A vaccine immunogenicity and protection in Mozambican children

A candidate antibody drug for prevention of malaria

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Restricted valency (NPNA)_n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum

Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model

In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Antibody responses to the RTS,S/AS01_E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Author Correction: Antibody responses to the RTS,S/AS01_E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis

Author Correction: Antibody responses to the RTS,S/AS01_E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique

Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Search

Quick links